These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17236813)

  • 1. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells.
    Donmez A; Zoghi M; Cagirgan S; Acarlar C; Tombuloglu M
    Transfus Apher Sci; 2006 Jun; 34(3):245-51. PubMed ID: 16931400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
    Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
    Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
    Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
    Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.
    Alessandrino P; Bernasconi P; Caldera D; Colombo A; Bonfichi M; Malcovati L; Klersy C; Martinelli G; Maiocchi M; Pagnucco G; Varettoni M; Perotti C; Bernasconi C
    Bone Marrow Transplant; 1999 Mar; 23(6):533-7. PubMed ID: 10217182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
    Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
    Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells.
    Bambace NM; Lachance S
    Ann Hematol; 2013 Nov; 92(11):1571-2. PubMed ID: 23580150
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
    Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
    Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
    Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
    Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac arrhythmia after infusion of cryopreserved stem cells.
    Keung YK; Lau S; Elkayam U; Chen SC; Douer D
    Bone Marrow Transplant; 1994 Sep; 14(3):363-7. PubMed ID: 7994256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
    Otrock ZK; Beydoun A; Barada WM; Masroujeh R; Hourani R; Bazarbachi A
    Haematologica; 2008 Mar; 93(3):e36-7. PubMed ID: 18310533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
    Marcacci G; Corazzelli G; Becchimanzi C; Arcamone M; Capobianco G; Russo F; Frigeri F; Pinto A
    Bone Marrow Transplant; 2009 Jul; 44(2):133-5. PubMed ID: 19182835
    [No Abstract]   [Full Text] [Related]  

  • 19. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.
    Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø
    Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
    Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
    Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.